US 11420976
Heterocyclic compounds as anti-viral agents
granted A61KA61K45/06
Quick answer
US patent 11420976 (Heterocyclic compounds as anti-viral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K45/06